Evidence map›Paper›PMID 41155205›Full record

ArticleInternational journal of molecular sciences2025

Analysis of the Phenolic Profile of

Ana Borges, José Luis Ordóñez-Díaz, Yara Aquino, José Manuel Moreno-Rojas, María Luisa Martín Calvo, Josiana A Vaz, Ricardo C Calhelha

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Molecular and Pharmacokinetic Rationale for the Use ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ana BorgesCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0009-0009-8809-0541
José Luis Ordóñez-DíazDepartment of Agroindustry and Food Quality, Andalusian Institute of Agricultural and Fisheries Research and Training (IFAPA) Alameda del Obispo, Avda. Menéndez-Pidal s/n., 14004 Córdoba, Spain.ORCID 0000-0001-5014-9047
Yara AquinoCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.
José Manuel Moreno-RojasDepartment of Agroindustry and Food Quality, Andalusian Institute of Agricultural and Fisheries Research and Training (IFAPA) Alameda del Obispo, Avda. Menéndez-Pidal s/n., 14004 Córdoba, Spain.ORCID 0000-0002-9372-1346
María Luisa Martín CalvoGrupo de Investigación en Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno s/n, 37007 Salamanca, Spain.ORCID 0000-0003-4810-9673
Josiana A VazResearch Center for Active Living and Wellbeing (LiveWell), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-6989-1169
Ricardo C CalhelhaCIMO, LA SusTEC, Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal.ORCID 0000-0002-6801-4578

Funding

Fundação para a Ciência e Tecnologia PTDC/BTA-BTA/0696/2020
6 · The paper itself

Abstract

The incorporation of bioactive natural compounds into biomedical applications offers a promising route to enhance therapeutic efficacy while supporting sustainability. In this study, we investigated the synergistic potential of Sericin, a silk-derived biopolymer, and

Indexed as

Anti-Bacterial AgentsChelidonium majusPhenolsPlant ExtractsSericinsDrug SynergismFibroblastsGram-Positive BacteriaHumansMaterials TestingSolid Phase ExtractionAnti-Bacterial AgentsPhenolsPlant ExtractsSericinsantimicrobialbiomaterialcytocompatibilitygreater celandineHPLC-MS/MSphenolic compoundssilksustainable healthcare

Identifiers

PMID41155205
PMCPMC12563533

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.